Renaissance Global Limited has allotted 7,500 equity shares of face value ₹2 each, fully paid-up, pursuant to the exercise of employee stock options under the 'Renaissance Global – Employee Stock Option Scheme 2021' (RGL ESOP 2021). The allotment was approved by the Nomination and Remuneration Committee via circular resolution on September 01, 2026.

The exercise price per share was ₹2, with no premium paid. The total money realized from the exercise of options was ₹8,25,000.

Consequent to this allotment, the company's paid-up equity share capital has increased from ₹21,47,92,942 (comprising 10,73,96,471 equity shares) to ₹21,48,07,942 (comprising 10,74,03,971 equity shares).

The allotted shares will rank pari-passu with the existing equity shares of the company in all respects. The company will apply for listing of these 7,500 equity shares on both the National Stock Exchange of India Limited (NSE) and BSE Limited.

The ISIN for the shares is INE722H01024. The distinctive numbers of the allotted shares range from 10,73,96,472 to 10,74,03,971 (both inclusive).

Compliance Details:

The disclosure is made pursuant to Regulation 30 read with Para B of Part A of Schedule III of the SEBI Listing Regulations, and includes additional details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

The scheme was originally approved by shareholders through a postal ballot on January 21, 2022. The company had previously filed the scheme statement with the stock exchanges on January 28, 2022, under filing references BSE-DCS/IPO/MJ/ESOP-IP/2235/2021-22 and NSE- NSE/LIST/29860.

ESOP Scheme Details:

The RGL ESOP 2021 covers a total of 20,28,702 options granted across seven grants (Grant-1 to Grant-7). Options under Grant 1, 2 and 3 are exercisable at ₹110 each, while options under Grant 4, 5, 6 and 7 are exercisable at ₹2 each.

Detailed vesting information was provided:

  • Grant-1: 6,25,000 options granted with vesting dates on 11/04/2023 (1,56,250), 11/04/2024 (1,56,250), 11/04/2025 (1,43,750), and 11/04/2026 (98,750). 70,000 options were cancelled due to resignations.
  • Grant-2: 8,05,000 options granted with vesting dates on 11/04/2023 (1,91,250), 11/04/2024 (1,91,250), 11/04/2025 (1,91,250), and 11/04/2026 (1,91,250). 40,000 options were cancelled.
  • Grant-3: 30,000 options granted with vesting on 06/01/2024 (7,500 and 22,500). 22,500 options were cancelled due to resignation.
  • Grant-4: 3,59,562 options granted with vesting on 06/01/2024, but all were cancelled due to termination before vesting date.
  • Grant-5: 51,000 options granted with vesting on 12/06/2026.
  • Grant-6: 1,07,140 options granted with vesting on 23/01/2026. 53,570 options were surrendered/relinquished by the grantee.

Options vested can be exercised within 3 years from respective vesting dates. The diluted earnings per share pursuant to this issue of equity shares is 0.95 per share.

Additional Information:

No significant variations in terms of options, subsequent changes, cancellations, or lock-in arrangements apply to these shares. No listing fees are payable for this allotment.